But the executive would prefer industry watchers gawk at the billions of dollars’ worth of deals his company has struck. Alex Zhavoronkov, CEO of Insilico Medicine, slides into the tall chair next to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results